Ruben Rizzi
Company: BioNTech AG
Job title: Senior Vice President - Global Regulatory Affairs
Seminars:
Developing a Fully Individualized mRNA Cancer Immunotherapy: Regulatory Innovation & Challenges 9:30 am
Lessons learned from the development of fully individualized mRNA immunotherapy across multiple tumor types Key questions to identify the most appropriate development strategy Navigating an evolving regulatory landscape and identifying the areas of uncertainty Virtual SessionRead more
day: Conference Day Two